Filing Details
NOVAVAX INC (NASDAQ:NVAX) filed a Form 8-K with the Securities and Exchange Commission on November 05, 2026, disclosing a material event.
8k filedNASDAQ:NVAX
NOVAVAX INC (NVAX) Reports Material Event to SEC
NOVAVAX INC (NASDAQ:NVAX) filed a Form 8-K with the Securities and Exchange Commission on November 05, 2026, disclosing a material event.
At publication ·
What changed
NOVAVAX INC (NASDAQ:NVAX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Novavax filed a Form 8-K with the SEC on November 5, 2026, disclosing a material event that shareholders should know about.
- The company's stock trades at $10.65 with a market capitalization of $1.1 billion.
- 8-K filings report material events such as leadership changes, acquisitions, asset sales, or changes to financial guidance.
Market Context
NOVAVAX INC's stock currently trades at $10.65 with a market capitalization of $1.1B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NOVAVAX INC's stock.
All SEC filings for NOVAVAX INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NVAX Stock Page
Frequently Asked Questions
Where can I read NVAX's SEC filings?
Browse all filings on our NVAX SEC filings page.
What types of SEC filings does NOVAVAX INC file?
Public companies like NOVAVAX INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.